文献速递银屑病与炎症性皮肤病

Tapinarof治疗银屑病:新型芳香烃受体调节剂独特作用机制综述

Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent.
PubMed 文献 · J Am Acad Dermatol · 2020-11-03

本文综述了新型首创新药局部芳香烃受体(AhR)调节剂Tapinarof治疗银屑病的作用机制。Tapinarof通过特异性结合并激活AhR,下调包括白介素17在内的促炎细胞因子,并调节皮肤屏障蛋白表达以促进屏障正常化,从而解释其在早期临床试验中显示的显著疗效和可接受的耐受性。

要点

  • Tapinarof是首创新药局部AhR调节剂,正在开发用于银屑病和特应性皮炎。
  • 其疗效源于激活AhR后下调IL-17等促炎因子并调节皮肤屏障蛋白表达。
  • AhR信号在免疫细胞和皮肤细胞基因表达调控及皮肤稳态中起关键作用。

核心结论

  • Tapinarof通过特异性结合并激活AhR,下调促炎细胞因子并调节皮肤屏障蛋白表达,从而发挥治疗银屑病的疗效。

研究设计与样本

  • 本文为综述,总结了Tapinarof的作用机制及早期临床试验中观察到的疗效与耐受性。

主要发现

  • Tapinarof特异性结合并激活AhR,下调包括白介素17在内的促炎细胞因子。
  • Tapinarof调节皮肤屏障蛋白表达以促进皮肤屏障正常化。
  • AhR信号调控免疫细胞和皮肤细胞的基因表达,在皮肤稳态中起关键作用。
  • 早期临床试验中Tapinarof乳膏治疗银屑病显示出显著疗效和可接受的耐受性。

临床怎么用

  • Tapinarof作为局部AhR调节剂,为银屑病治疗提供了新的作用机制选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tapinarof, a novel, first-in-class, small-molecule topical therapeutic aryl hydrocarbon receptor (AhR)-modulating agent, is in clinical development for the treatment of psoriasis and atopic dermatitis. The efficacy of tapinarof in psoriasis is attributed to its specific binding and activation of AhR, a ligand-dependent transcription factor, leading to the downregulation of proinflammatory cytokines, including interleukin 17, and regulation of skin barrier protein expression to promote skin barrier normalization. AhR signaling regulates gene expression in immune cells and skin cells and has critical roles in the regulation of skin homeostasis. Tapinarof-mediated AhR signaling underlies the mechanistic basis for the significant efficacy and acceptable tolerability observed in early-phase clinical trials of tapinarof cream in the treatment of psoriasis.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Bissonnette R, Stein Gold L, Rubenstein DS, et al. Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent. J Am Acad Dermatol. 2020. PMID: 33157177. doi:10.1016/j.jaad.2020.10.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。